PropertyValue
?:abstract
  • Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.
?:creator
?:journal
  • Diabetes_Metab_Res_Rev
  • Diabetes_metab._res._rev
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story
?:type
?:who_covidence_id
  • #32592507
  • #615188
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ukgg21mz>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ukgg21mz>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all